Merck KGaA, Darmstadt, Germany utilizes genetically modified organisms in research and development. Since the 1980s, Merck KGaA, Darmstadt, Germany has been manufacturing biotech products that are produced using genetically modified organisms (GMOs). Without this technology, the major medical advances of the last several years would not have been possible.
Our major research centers for medical biotechnology are located in Darmstadt (Germany), Boston (United States), Beijing (China), and Tokyo (Japan). Important production sites for this are Aubonne and Corsier-sur-Vevey in Switzerland. In 2012, we completed the expansion of our site in Corsier-sur-Vevey. Now one of the most state-of-the-art biotech production facilities in Europe, it has enabled us to bolster our market-leading position in this field.
All biotechnological activities at Merck KGaA, Darmstadt, Germany are subject to strict legal regulations worldwide; compliance with these regulations is monitored by biological safety officers. Merck KGaA, Darmstadt, Germany continually tracks regulatory changes pertaining to biotech products and adapts its processes accordingly, thus ensuring compliance with all statutory requirements.